The Coronavirus vaccine race is currently going on in this world as WHO focusses on the different trials going on in this world. Recently, Bharat Biotech released information on their upcoming vaccine named Covaxin which aims to cure the deadly pandemic before August 15. Similarly, Oxford University is currently focussing on its research-based on hydroxychloroquine and other similar test drugs.
WHO recently received a $3 billion funding in order to continue all such research-based work globally. The World Health Organization has said that it is expecting results from clinical trials it is conducting of drugs that might be effective in treating COVID-19 patients, within two weeks.
WHO will have a cure ready within weeks
The organization expects interim results within the next two weeks. WHO Director-General Tedros Adhanom Ghebreyesus says nearly 5,500 patients in 39 countries have so far been recruited into the Solidarity trial, referring to the clinical studies the U.N. agency is conducting.
Research & innovation have played a vital role since the beginning of #COVID19. @WHO held a 2nd R&D forum with 1000+ scientists to take stock of progress, discuss new research questions & knowledge gaps, & define future research priorities. https://t.co/IzzLalGj0N
— Tedros Adhanom Ghebreyesus (@DrTedros) July 2, 2020
The Solidarity Trial started out in five parts looking at possible treatment approaches to COVID-19 which includes standard care, remdesivir, the anti-malaria drug touted by U.S. President Donald Trump, hydroxychloroquine, the HIV drugs lopinavir/ritonavir, and lopinavir/ritonavir combined with interferon.
Recently WHO stopped the arm testing hydroxychloroquine, after studies indicated it showed no benefit in those who have the disease, but more work is still needed to see whether it may be effective as preventative medicine. WHO officials have defended their response to the virus that emerged in China last year, saying they had been driven by the science as it developed.
Let us know what you have to say about this in the comments section below! Also, do not forget to join us on our Telegram Channel for instant updates of the science and tech world.
Suryapratim Ray is an engineer, author, robotics hobbyist, and an active Quoran. Being a technical blogger, he covers the good, bad, and ugly of science on a regular basis at Sciencenews18. In addition to his passion for writing, he’s equally keen on learning classical music.